1. Home
  2. GPK vs ABCL Comparison

GPK vs ABCL Comparison

Compare GPK & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graphic Packaging Holding Company

GPK

Graphic Packaging Holding Company

HOLD

Current Price

$11.96

Market Cap

3.0B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.32

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPK
ABCL
Founded
2007
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.5B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
GPK
ABCL
Price
$11.96
$11.32
Analyst Decision
Hold
Strong Buy
Analyst Count
9
5
Target Price
$13.08
$8.40
AVG Volume (30 Days)
4.4M
8.7M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
4.58%
N/A
EPS Growth
N/A
10.91
EPS
N/A
N/A
Revenue
$8,617,000,000.00
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.15
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
160.56
52 Week Low
$8.79
$2.75
52 Week High
$23.06
$12.15

Technical Indicators

Market Signals
Indicator
GPK
ABCL
Relative Strength Index (RSI) 59.12 73.83
Support Level $9.95 $3.38
Resistance Level $12.25 N/A
Average True Range (ATR) 0.44 0.87
MACD -0.03 0.35
Stochastic Oscillator 80.60 87.21

Price Performance

Historical Comparison
GPK
ABCL

About GPK Graphic Packaging Holding Company

Graphic Packaging Holding Co is a holding company that manufactures and sells a variety of paper-based consumer packaging products through its subsidiaries. The company's reportable segments are; Americas Paperboard Packaging, and International Paperboard Packaging. The majority of the revenue is generated from its Americas Paperboard Packaging segment which includes paperboard packaging sold predominantly to consumer packaged goods (CPG) companies and cups, lids and food containers sold to foodservice companies and quick-service restaurants (QSR) serving the food, beverage, and consumer product markets in the Americas. Geographically, the company operates in Americas, Europe and Asia Pacific regions.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: